Sangrix vs Sentage Holdings
Sentage Holdings is the larger business, with $68,909 of revenue in fiscal 2025 against $39,495 for Sangrix (1.7 times as much). Sentage Holdings grew faster (-35.9% against -98.6%). Sentage Holdings kept more of each dollar of sales as profit: a net margin of -3305.2% against -16543.8%.
| Latest fiscal year | SangrixSGRX, 2025 | Sentage HoldingsSNTG, 2025 |
|---|---|---|
| Revenue | $39,495 | $68,909 |
| Revenue growth | -98.6% | -35.9% |
| Net income | −$6.5m | −$2.3m |
| Operating margin | -7574.9% | -3301.3% |
| Net margin | -16543.8% | -3305.2% |
| Return on equity | — | -25.2% |
| Free cash flow | −$2.3m | −$1.3m |
| Cash | $55,639 | $477,624 |
| Total debt | — | $0 |
| Debt to equity | — | 0.0% |
| Dividend per share | — | — |
| Dividend yield | — | 0.0% |
| Share buybacks | — | — |
| Employees | — | — |
| Market value | $256,812 | $4.5m |
| Price vs our value range | — | — |
| Moat score | — | — |
| Insider trades, 12 months | 0 buys, 0 sales | 0 buys, 0 sales |